HSPB1 and serum lipopolysaccharide activity: Our work highlights canagliflozin’s protective effects on endotoxemia-induced vascular hyperpermeability and demonstrates that endothelial α1AMPK and its downstream p38MAPK/HSP27/VE-Cad regulatory pathway are involved in this protection.